Purpose Study the contribution of long non-coding RNAs (lncRNAs) to progression of pancreatic intraepithelial neoplasia (PanIN) to pancreatic ductal adenocarcinoma (PDAC). Methods We explored lncRNAs profilings in PanIN cell line (SH-PAN) isolated from Pdx-1-Cre; LSL-Kras G12D/+ mice and PDAC cell line (DT-PCa) isolated from Pdx-1-Cre; LSL-Kras 
INTRODUCTION
Pancreatic cancer, with an overall 5-year survival rate of <5%, is the fourth leading cause of cancer death in the past few years (1, 2) . The overwhelming majority of patients present with non-localized and metastatic diseases which is inoperable (3) . Tp53 is one of the most referenced and well-known pancreatic cancer suppressors which is inactivated in approximately 50%-75% of pancreatic cancers. Alterations of Tp53 protein function permit cells to bypass DNA damage checkpoints and apoptotic signals (4) . Evidence is accumulating that loss of Tp53 function may bring about genomic instability in pancreatic cancers (5, 6 ). In addition, several studies have concluded that Wnt pathway play a crucial role in pancreatic carcinogensis (7) (8) (9) . Can we hypothesize a connection between Tp53 mutation and Wnt pathway-associated genes? In order to thoroughly confirm the hypothesis, lncRNA/mRNA expression profilings were identified. LncRNAs are understood as noncoding RNAs that longer than 200 and less than 100,000 nucleotides in length. LncRNAs take part in several intracellular regulation cascades, however, abnormal regulation of lncRNAs is determined to be mostly correlated to many diseases. There is a growing body of evidence pointing to the sense that lncRNAs exert key roles in several kinds of carcinogensis (10) (11) (12) (13) (14) (15) . But little is known on the expression of lncRNAs and their biological functions in pancreatic cancer.
In our study, we applied the lncRNA/mRNA expression profiles in three pairs of PanIN cell line SH-PAN isolated from genetically engineered Pdx-1-Cre; LSL-Kras G12D/+ mutant mice and PDAC cell line DT-PCa isolated from the Pdx-1-Cre; LSLKras G12D/+ ; LSL-Tp53 R172H/+ compound mutant mice. The selected lncRNAs and protein-coding genes associated with Wnt pathway were further validated by real-time PCR and Western blot. Our results show that lncRNA/mRNA expression profiling may provide new molecular biomarkers for the pancreatic carcinogenesis.
MATERIALS AND METHODS

Patients and Tissue Samples
Fresh PDAC tissues from 26 patients and matched histological normal pancreatic tissues were obtained from patients who underwent surgery in the Department of Surgery at Ruijin Hospital in Shanghai. No patient received radiotherapy or chemotherapy before surgery. Tissues from each subject were snap-frozen in liquid nitrogen immediately after resection. Total RNA was extracted from 26 pairs of snap frozen PDAC tissues and matched histological normal pancreatic tissues using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol.
Also, PDAC tissue samples and matched peritumoral tissue samples were obtained from 107 patients who underwent surgery in Ruijin Hospital in Shanghai. Tissue samples included peritumoral normal pancreatic tissues, PanIN tissues and invasive carcinoma. None of the patients had received radiotherapy or chemotherapy before surgery. After surgery, each tissue sample was fixed in formal and embedded in paraffin. Histological diagnosis was performed by two independent senior pathologists in the Department of Pathology in Ruijin Hospital.
Mouse Strain and Cell Lines
PanIN cell SH-PAN was isolated from the pancreas of a 4-month-old genetically engineered Pdx1-Cre; LSL-Kras G12D mutant mice, and PDAC cell DT-PCa was isolated from the pancreas of Pdx-1-Cre; LSL-Kras G12D/+ ; LSL-Tp53 R172H/+ compound mutant mice as we previously described (5,6) (16). Both cell lines were grown in 10%FCS/DMEM/ 25 mM HEPES and supplemented with 100 U/ml penicillin, and 100 mg/ml streptomycin at 37°C with 5%CO 2 .
Microarray and Computational Analysis
To extract total RNA, 1×10 6 SH-PAN and DT-PCa cells were harvested with the Trizol Reagent (Invitrogen, Carlsbad, CA, USA). Total RNA from each sample was quantified using the NanoDrop ND-1000 and the RNA integrity was assessed using standard denaturing agarose gel electrophoresis. For microarray analysis, Agilent Array platform was employed. The sample preparation and microarray hybridization were performed based on the manufacturer's standard protocols with minor modifications. Briefly, mRNA was purified from total RNA after removal of rRNA (mRNA-ONLY™ Eukaryotic mRNA Isolation Kit, Epicentre). Then, each sample was amplified and transcribed into fluorescent cRNA along the entire length of the transcripts without 3′ bias utilizing a random priming method. The labeled cRNAs were hybridized onto the Mouse LncRNA Array v2.0 (8×60 K, Arraystar). After having washed the slides, the arrays were scanned by the Agilent Scanner G2505B. Agilent Feature Extraction software (version 10.7.3.1) was used to analyze the acquired array images. Quantile normalization and subsequent data analysis were performed in the GeneSpring GX v11.5.1 software package (Agilent Technologies). After quantile normalization of the raw data, LncRNAs and mRNAs that at least 1 out of 6 samples have flags in Present or Marginal ("All Targets Value") were chosen for further data analysis. Finally, Hierarchical Clustering was performed to show the distinguishable LncRNAs and mRNAs expression pattern among samples.
Coexpression Network
Gene-coexpression networks were built according to the normalized signal intensity of differentially expressed genes. We constructed the network adjacency between two genes, defined as a power of the Pearson correlation between the corresponding gene-expression profiles. To make a visual representation, only the strongest correlations (0.99 or greater) were drawn in these renderings. In gene-coexpression networks, each gene corresponds to a node. Two genes are connected by an edge, indicating a strong correlation (i.e., either positive or negative).
Reverse Transcription and Quantitative Real-Time PCR Assay
To validate gene expression changes,Reverse transcription and quantitative real-time PCR were employed. The primer sequences are shown in Table I . The assays were done using ABI PRISMs 7300 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). The relative quantification of lncRNAs and mRNAs expression was determined using the comparative C T method. LncRNAs and mRNAs expression in DT-PCa cells relative to the SH-PAN cells was calculated using the following formulas: ΔΔCT=ΔCT DTPCa-ΔCT SH-PAN, fold change=2 -ΔΔCT (17) .
Western Blotting Analysis
Preparation of whole-cell lysates and electrophoresis were done as we described previously (18) . All primary antibodies used were rabbit polyclonal anti-mouse antibodies, including Rac1 antibody (1:1,000, ab78139, Abcam, UK), Rhoa antibody (1:1,000, ab68826, Abcam, UK), Ppp3ca antibody (1:1,000, ab3673, Abcam, UK), Ruvbl1 antibody (1:1,000, ab51500, Abcam, UK), Ppp3cb antibody (1:1,000, ab96573, Abcam, UK). HRP-conjugated goat anti-rabbit IgG antibody (1:3,000, Imgenex) was used as secondary antibody. Immunodetection was carried out using the ECL Western-blotting detection kit (Amersham Corp, UK). Relative protein expression levels were quantified by densitometric measurement of ECL reaction bands and normalized with values of GAPDH. 
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed using the EZ ChIP™ Chromatin Immunoprecipitation Kit (Millipore Bedford, MA, USA) according to its manual. The chromatin was immunoprecipitated using Tp53 rabbit polyclonal anti-mouse antibody (Cell Signaling Technology). Normal rabbit polyclonal anti-mouse antibody IgG was used as negative control. Primer sequences are listed in Table I .
Histology and Immunohistochemistry
Detailed procedures are provided as we described previously (19, 20) . Briefly, tissues were fixed in 10% formalin overnight and then embedded in paraffin. Serial 5-μm thick sections from the tissue blocks were cut, and were dried overnight in a 60°C oven. The sections were dewaxed in xylene and dehydrated through graded alcohol to water, and then were stained in H&E for histological verification. For immunohistochemistry, the sections were dried overnight in a 60°C oven and then dewaxed in xylene, rehydrated through graded alcohol to water. After antigen retrieval with 0.01% EDTA (pH 8.0), endogenous peroxidase activity was blocked with 1% hydrogen peroxide in distilled water for 25 min followed by washing with distilled water and finally PBS+0.1% Tween for 5 min. Rabbit anti-mouse polyclonal antibody to Ppp3ca (1:75, PAB10422, Abnova) was used as the primary antibody. Signal detection was accomplished with biotinylated antirabbit secondary antibody (1:200, Santa Cruz) using the Elite Vectastain ABC kit and peroxidase substrate DAB kit (Vector Laboratories, Burlingame, CA). The evaluation of immunohistochemical staining of Ppp3ca in PDAC and paired peritumoral tissues was defined as detectable immunoreaction in perinuclear and/or cytoplasm and was semiquantitatively estimated from intensity of staining as previously described (19, 20) : grade 0 (no staining), grade 1 (weak staining), grade 2 (moderate staining) and grade 3 (strong staining). The percentage of positive cells was scored from grade 0 to grade 3. Grade 0, <1% of the cancer cells stained or with complete absence of staining; Grade 1, 1% to 49% positive expression; Grade 2, 50% to 70% positive expression; and Grade 3, >70% positive expression.
Statistical Analysis
All the statistical analyses were performed using SPSS version 17.0 software. The results were presented as means±SD. Significant changes were assessed using Student's t tests, and p values<0.05 was considered significant. To determine the correlation between Tp53 mutation status and lincRNA1611 levels in the human pancreatic carcinoma specimens, Wilcoxon Rank-Sum test was used.
RESULTS
Overview of LncRNAs/mRNAs Profiles
In our study, Arraystar Mouse LncRNA Microarray v2.0 is designed for the global profiling of mouse lncRNAs and protein-coding transcripts. 15035 lncRNAs and 12442 coding transcripts can be detected by our second-generation lncRNA microarray. The lncRNAs are carefully collected from the most authoritative databases such as RefSeq, UCSC Known genes, Ensemble and many related literatures. Each transcript is represented by a specific exon or splice junction probe which can identify individual transcript accurately. Positive probes for housekeeping genes and negative probes are also printed onto the array for hybridization quality control. From the microarray data, we compared the lncRNAs/mRNAs expression levels and identified 319 upregulated lncRNAs, 571 downregulated lncRNAs (≥2-fold changes) in DT-PCa cells compared to SH-PAN cells (Table S1 ). A collcetion of most significantly upregulated and down-regulated lncRNAs with more than fivefold changes was listed in Table II . From these differentially expressed lncRNAs, we listed 105 lincRNAs (large intergenic noncoding RNAs) with more than two-fold changes (Table III) . The lincRNAs may locate on the upstream or downstream of the nearby coding genes (distance <300 kb). Up to 12,442 detected coding transcripts probes, we discovered 1,106 upregulated mRNAs, 407 downregulated mRNAs (≥2-fold changes) in PDAC cell DT-PCa compared with PanIN cell SH-PAN (Table S2) . We next categorized the signaling pathways identified through microarray assay. Using Ingenuity Pathway Analysis, we determined the genes were involved in more than 20 different signaling pathways. The most prominent of these pathways was the Focal adhesion, Wnt, cell cycle, tight junction, Jak-STAT signaling pathways and so on (Table S3) .
In order to identify differentially expressed lncRNAs or mRNAs with statistical significance, we performed a volcano plot filtering between the two compared groups respectively. The threshold was fold change ≥2.0, p-value<0.05 (Fig. 1a and c) . Hierarchical clustering is one of the most widely used clustering methods for analyzing RNA expression data. Cluster analysis arranged samples into groups based on their expression levels, which allowed us to hypothesize the relationships among samples. The dendrogram showed the relationships among lncRNA or mRNA expression patterns of samples ( Fig. 1b and d) .
Alteration of Wnt-Associated LncRNAs/mRNAs Expression
Based on the key role of Wnt pathway in carcinogenesis, we subsequently selected Wnt-associated lncRNAs/mRNAs through current data from the microarray and bioinformatics. According to the Pathway Analysis, we listed all 17 differentially expressed mRNAs in Wnt pathway (Table IV) . In the coexpression network, five protein coding genes in Wnt pathway displayed a strong correlation with eight lncRNAs (Fig. 2a ) (Table S4) . Next, the eight lncRNAs (lincRNA1611, ENSMUST00000052615, ENSMUST00000122008, ENSMUST00000110798, ENSMUST00000119417, ENSMUST 00000 170943, ENSMUST00000120497, ENSMUST00000056452) and the five mRNAs (Rhoa, Ruvbl1, Rac1, Ppp3ca, Ppp3cb) were selected to validate the consistency by real-time PCR. Results showed a strong consistency in all the selected lncRNAs and mRNAs between the real-time PCR results and microarray data (Fig. 2b) . Of them, seven lncRNAs and five protein coding genes were upregulated in DT-PCa cells, (Fig. 2c) .
In addition, we also validated the consistency between the real-time PCR results and microarray data in the other Wntassociated 12 mRNAs (Ppp3r1, Ppp2r1a, Skp1a, Ppp2r5e, Ctbp2, Wnt11, Wisp1, Mapk9, Ctbp1, Ppp2r5d, Plcb1 and Cul1) (Fig. S1 ). 
Tp53 Mutation Status Positively Correlates with High Expression of lincRNA1611 and Ppp3ca in PDAC
In order to identify whether Tp53 R172H may directly promote the expression of the protein-coding genes, we conducted ChIP analysis in DT-PCa cells compared to SH-PAN cells. The results demonstrated that Tp53 R172H directly acted on Ppp3ca and promoted the expression of Ppp3ca (Fig. 3a) . However, the results concerning the other four genes, including Ruvbl1, Rac1, Rhoa and Ppp3cb, did not reveal direct interactions with Tp53 R172H (data not shown). It indicates that Tp53 R172H may increase the expression of Ppp3ca. Based on the fact that lincRNA1611 is the only one locates on the upstream of the nearby coding genes Ppp3ca (distance< 300 kb) among the 105 differentially expressed lincRNAs (≥2-fold changes), and the unknown expression and clinical significance of the Ppp3ca gene in PDAC, next, we compared the levels of Ppp3ca mRNA and HMlincRNA1611 (a human ortholog RNA of lincRNA1611) between 26 PDAC tissue samples and the matched normal pancreatic tissues by realtime PCR. Results showed that the expression of HMLincRNA1611 (p=0.001) and Ppp3ca (p=0.001) was significantly higher in 22 PDAC tissue samples than that in matched normal pancreatic tissues (Fig. 3b) , in which Tp53 mutation were detected in 14 of 26 PDAC tissue samples. Moreover, we detected the relationship between Tp53 mutation status and lincRNA1611 levels or Ppp3ca mRNA levels (ΔCt value) in the fresh human pancreatic carcinoma specimens. Results showed that the expression of both lincRNA1611 and Ppp3ca in the 14 PDAC tissue with Tp53 mutation were higher than that in the 12 PDAC tissue with wild type Tp53. Tp53 mutation status displayed a strong positive correlation with lincRNA1611 levels(p=0.008) or Ppp3ca mRNA level(p= 0.015) (Fig. 3c) .
These results indicate that Tp53 mutation may influence the expression of Ppp3ca.
Dynamic Alteration of Ppp3ca Expression in Human PDAC Tissues
Moreover, we detected the protein level of Ppp3ca in human PDAC tissue samples to evaluate the clinical significance in human pancreatic cancer. Immunohistochemistry was employed in 107 human PDAC tissues and paired peritumoral tissues. Of them, 29 PanIN-I tissues, 16 PanIN-II tissues and 27 PanIN-III tissues were observed by hematoxylin and Eosin (H&E) staining (Fig. 4a) . Immunohistochemical results are summarized in bar chart and the percentage of cells with grade 0, 1, 2 and 3 staining (Fig. 4b) . Ppp3ca expression was detected in 91 normal pancreatic tissues, 24 PanIN-I tissues and 13 PanIN-II tissues with low level staining (grades 0 and 1) of nucleus and cytoplasm. In contrast, Ppp3Ca expression was observed in 10 PanIN-III tissues and 62 PDAC tissues with high level staining (grades 2 and 3) of nucleus and cytoplasm. These results indicate that the expression of lincRNA1611 and Ppp3ca is high in PDAC tissues, over-expression of lincRNA1611 and Ppp3ca is probably involved in PDAC.
DISCUSSION
Many researchers are drawing out an update view of lncRNA and proving the possible underlying molecular mechanism of some cancer-related lncRNAs. As known, a complicated progressive course through several signaling pathways and a series of gene mutations are involved in tumorigenesis. Of them, Wnt is one of the most cardinal signaling pathways and Tp53 is one of frequent mutation genes in pancreatic carcinogenesis (21, 22) .
Our previous studies showed that expression of mutant Kras was sufficient to initiate PanINs, but it was not enough for developing invasive cancer (5, 6, 16) . In Pdx-1-Cre; LSLKras G12D/+ mice of average age of 4.5 months, the majority of duct lesions in pancreas were low PanIN (PanIN IA and 1 B) , rare PanIN III was observed, no carcinoma occurred. Pdx-1-Cre; LSL-Kras G12D/+ ; LSL-Tp53 R172H/+ compound mutant mice developed invasive pancreatic ductal adenocarcinoma. Tp53 ; LSLTp53 R172H/+ compound mutant mice. Our study focused on displaying the lncRNAs expression profiles of genetically engineered mice cell lines, and the further explanation between the PanIN cells and PDAC cells. Differentially expressed lncRNAs/mRNAs between SH-PAN cells and DT-PCa cells were identified by microarray and the selected lncRNAs/ mRNAs were tested and validated by real-time PCR. According to the microarray data and previous work, 8 lncRNAs and 5 mRNAs were selected to validate the consistency. LncRNA ENSMUST00000052615 is 914 bp intergenic RNA stems from the gene ENSMUSG00000045799 located on Chromosome 14. ENSMUST00000122008 is 522 bp i n t e r g e n i c R N A d e r i v e d f r o m t h e g e n e ENSMUSG00000060795 located on Chromosome 2. ENSMUST00000110798 is 1,360 bp intergenic RNA transcribed from the gene ENSMUSG00000079139 located on Chromosome 1. ENSMUST00000056452 is 971 bp intergenic RNA came from the gene ENSMUSG00000046341 located on Chromosome 4. LncRNAs ENSMUST00000052615, ENSMUST00000122008, ENSMUST00000110798 and ENSMUST00000056452 were predicted related to some protein-coding genes such as Rhoa, Ruvbl1 and Rac1. Rhoa gene encodes protein RhoA(Ras homolog gene family, member A). RhoA is part of a larger family of related proteins known as the Ras superfamily; proteins involved in the regulation and timing of cell division. Rac1 gene encodes protein Rac1. Rac1, also known as Ras-related C3 botulinum toxin substrate 1, is a protein found in human cells. Guo X et al. (23) showed that progression of pancreatic tumors is partially controlled by the balance between Tiam1-rac1 and RhoA. Timpson P et al. (24) indicated that Tp53 mutation may drive pancreatic cancer cell invasion through spatial regulation of RhoA activity. Recent studies implicated the RuvbL1/RuvbL2 complexes in many cellular processes such as transcription, DNA damage response, snoRNP assembly, cellular transformation, and cancer metastasis (25) . LincRNA1611 is 402 bp intergenic RNA from the gene C A 5 8 5 6 4 3 l o c a t e d o n C h r o m o s o m e 3 . ENSMUST00000120497 is 207 bp antisense overlap RNA from the gene ENSMUSG00000084118 located on Chromosome X. ENSMUST00000170943 is 513 bp intergenic RNA from the gene ENSMUSG00000091223 located on Chromosome 3. ENSMUST00000119417 is 2,191 bp intergenic RNA from the gene ENSMUSG00000082896 located on Chromosome 3. ENSMUST00000170798 is 2,191 bp intergenic RNA from the gene ENSMUSG00000082896 located on Chromosome 3. The prognosis of several genes such as Ppp3ca and Ppp3c were associated with lncRNA ENSMUST00000120497, ENSMUST00000170943, ENSMUST00000170798 and LincRNA1611. Ppp3ca gene encodes protein Protein phosphatase 3, catalytic subunit, alpha isozyme(Ppp3ca) and Ppp3cb gene encodes protein Serine/ threonine-protein phosphatase 2C catalytic subunit beta isoform(Ppp3cb). Recent studies showed that Ppp3ca, Ppp3cb were bound up with carcinogenesis (26) (27) (28) .
Interestingly, we found that Tp53 R172H could directly act on Ppp3ca in mouse cell lines and the expression of lincRNA1611 and Ppp3ca were high in human PDAC tissues. Furthermore, Tp53 mutation status showed a strong positive relationship with the level of lincRNA1611 and Ppp3ca in PDAC. The expression of lincRNA1611 and Ppp3ca in PDAC tissue with Tp53 mutation was significantly higher than that in PDAC tissue with wild-type Tp53. Therefore, we speculate that Tp53 mutation induces the expression of Ppp3ca, the increased expression of HMlincRNA1611 and Ppp3ca may be associated with the progression of PDAC. However, how these lncRNAs act on and regulate the protein-coding genes still needs further study. Although we do not get sufficient evidence to utilize the 8 lncRNAs as the biomarkers in pancreatic carcinogenesis, the present data may help us to explore novel molecular markers in tumorigenesis.
The microarray also displayed a series of lincRNAs and the nearby associated protein-coding genes. In theory, overexpressing or silencing these lncRNAs may up-regulate or down-regulate the expression of their neighboring proteincoding genes. This is the first study that explores the expression profiling of lncRNAs in pancreatic cancer cells to elaborate pancreatic carcinogenesis. A collection of differentially expressed lncRNAs may play a part role as oncogenes or tumor suppressors in the progression of pancreatic carcinoma. Further work should be done to confirm whether these lncRNAs might regulate the known protein-coding oncogenes or tumor suppressors and determine whether they can serve as new therapeutic targets and diagnostic biomarkers in pancreatic carcinogenesis.
CONCLUSIONS
Our study provided an efficient and effective way to explore the alteration of lncRNAs or protein-coding genes associated with cardinal signaling pathways in the progression of carcinogenesis. The expression of lincRNA1611 and Ppp3ca was induced by Tp53 mutation, which may be involved in progression of pancreatic cancer and serve as new therapeutic targets and diagnostic biomarkers for pancreatic cancer.
